Health and Life Sciences Committee

Rich Buckley, AstraZeneca -  Chair

E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it.

About BABA

This Committee was created to address the issues associated with the 16% of US GDP devoted to health care, and assess the impact of the newly enacted health care reform law on businesses and individuals. The Committee hopes to provide information related to the expansion of insurance, the creation of new markets and government approaches to the delivery of services and products, and the potential impact on innovation. In addition to health care issues, the committee's focus includes the growing and dynamic field of bioscience technology.